Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

IQV

IQVIA Holdings Inc

Jul 26 • 04:00PM ET

239.67

Dollar change +7.38
Percentage change 3.18	%

Healthcare • Diagnostics & Research • USA • NYSE

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VOO VO SPY IVV XLV IBB VTV VOT IWR

Scroll to Statements

Index	S&P 500	P/E	31.08	EPS (ttm)	7.71	Insider Own	0.82%	Shs Outstand	181.50M	Perf Week	6.72%
Market Cap	43.69B	Forward P/E	19.22	EPS next Y	12.47	Insider Trans	-4.40%	Shs Float	180.81M	Perf Month	13.49%
Income	1.42B	PEG	2.92	EPS next Q	2.81	Inst Own	90.52%	Short Float	1.48%	Perf Quarter	2.43%
Sales	15.16B	P/S	2.88	EPS this Y	9.72%	Inst Trans	0.41%	Short Ratio	2.15	Perf Half Y	11.22%
Book/sh	36.83	P/B	6.51	EPS next Y	11.40%	ROA	5.43%	Short Interest	2.67M	Perf Year	3.32%
Cash/sh	9.20	P/C	26.04	EPS next 5Y	10.63%	ROE	22.84%	52W Range	167.42 - 261.73	Perf YTD	3.58%
Dividend Est.	-	P/FCF	23.91	EPS past 5Y	42.42%	ROI	7.49%	52W High	-8.43%	Beta	1.48
Dividend TTM	-	Quick Ratio	0.85	Sales past 5Y	7.76%	Gross Margin	27.57%	52W Low	43.15%	ATR (14)	6.47
Dividend Ex-Date	-	Current Ratio	0.85	EPS Y/Y TTM	32.25%	Oper. Margin	13.88%	RSI (14)	62.96	Volatility	3.39% 2.54%
Employees	87000	Debt/Eq	2.00	Sales Y/Y TTM	3.45%	Profit Margin	9.39%	Recom	1.65	Target Price	273.71
Option/Short	Yes / Yes	LT Debt/Eq	1.83	EPS Q/Q	23.81%	Payout	0.00%	Rel Volume	0.96	Prev Close	232.29
Sales Surprise	0.65%	EPS Surprise	2.94%	Sales Q/Q	2.53%	Earnings	Jul 22 BMO	Avg Volume	1.24M	Price	239.67
SMA20	8.29%	SMA50	8.41%	SMA200	7.69%	Trades		Volume	1,195,031	Change	3.18%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-24-24	Downgrade	Jefferies	Buy → Hold	$266 → $242
Jun-06-24	Initiated	Goldman	Buy	$270
Feb-26-24	Initiated	Leerink Partners	Outperform	$290
Feb-15-24	Downgrade	Guggenheim	Buy → Neutral
Feb-13-24	Initiated	BTIG Research	Buy	$285
Nov-02-23	Downgrade	Robert W. Baird	Outperform → Neutral	$248 → $202
Sep-06-23	Initiated	HSBC Securities	Buy	$260
Mar-17-23	Initiated	Truist	Buy	$265
Dec-06-22	Initiated	Cowen	Outperform	$251
Nov-17-22	Downgrade	Citigroup	Buy → Neutral	$275 → $245
Aug-25-22	Initiated	Credit Suisse	Outperform	$300
Jul-15-22	Initiated	SVB Leerink	Outperform	$256
May-24-22	Initiated	Guggenheim	Buy	$244
Apr-29-22	Upgrade	Piper Sandler	Neutral → Overweight	$231 → $255
Apr-25-22	Downgrade	Wells Fargo	Overweight → Equal Weight	$235
Aug-05-21	Resumed	Credit Suisse	Outperform	$272
Apr-16-21	Upgrade	Stephens	Equal-Weight → Overweight	$180 → $250
Mar-08-21	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$218
Mar-03-21	Initiated	Barclays	Overweight	$220
Jul-07-20	Initiated	Stephens	Equal-Weight	$150

Show Previous Ratings

Jul-25-24 06:18PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
Jul-24-24 03:26AM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
Jul-23-24 09:40AM	Here's Why IQVIA Holdings (IQV) is a Strong Value Stock (Zacks)
01:49AM	Q2 2024 IQVIA Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
01:00AM	Decoding IQVIA Holdings Inc (IQV): A Strategic SWOT Insight (GuruFocus.com)
06:30PM	Loading…
Jul-22-24 06:30PM	Compared to Estimates, IQVIA (IQV) Q2 Earnings: A Look at Key Metrics (Zacks) +9.20%
04:28PM	Iqvia Bolts Higher After A Surprise Segment Beat Saved Its Second Quarter (Investor's Business Daily)
01:47PM	IQVIA Stock Pops After It Beats Q2 Earnings Estimates (Investopedia)
11:25AM	IQVIA (IQV) Surpasses Earnings & Revenue Estimates in Q2 (Zacks)
10:37AM	IQVIA 'Is A Solid Investment' With Strong Competitive Positioning, Analyst Says After Better Than Expected Q2 Earnings (Benzinga)
08:15AM	IQVIA Holdings (IQV) Q2 Earnings and Revenues Surpass Estimates (Zacks)
07:11AM	IQVIA: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	IQVIA Reports Second-Quarter 2024 Results (Business Wire)
Jul-17-24 11:00AM	IQVIA (IQV) to Report Q2 Earnings: What's in the Offing? (Zacks)
Jul-16-24 06:28PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
06:02AM	Loading…
Jul-12-24 06:02AM	Will IQVIA Holdings (IQV) Bounce Back? (Insider Monkey)
Jul-11-24 08:30AM	IQVIA Named a Leader in Medical Affairs and Regulatory Operations by Everest Group (Business Wire)
Jul-08-24 04:15PM	IQVIA to Announce Second-Quarter 2024 Results on July 22, 2024 (Business Wire)
Jul-01-24 08:01AM	Clinical Development Expertise Aids IQVIA (IQV), Costs High (Zacks)
Jun-25-24 08:00AM	IQVIAs SmartSolve eQMS Wins 2024 MedTech Breakthrough Award Best Use of Artificial Intelligence in Healthcare (Business Wire)
Jun-18-24 08:49AM	The CRO Sector Looks Appealing, Says Goldman Sachs Here Are 2 Stocks to Consider (TipRanks)
06:13AM	Ranking the top ten clinical research organisations in the world (Pharmaceutical Technology)
Jun-13-24 12:23PM	IQVIA (IQV) Announces Launch of Trial Technology Platform (Zacks)
04:32AM	IQVIA introduces new trial technology platform for research sites (Clinical Trials Arena)
Jun-12-24 08:00AM	IQVIA Launches One Home Clinical Trial Technology Platform Solves Challenges and Reduces Overload at Sites (Business Wire)
Jun-10-24 08:00AM	IQVIA Institute: Innovative Therapies and Strong Pipeline to Combat Rise in Cancer Diagnoses (Business Wire)
Jun-06-24 03:07PM	Final Trades: Amazon, Goldman Sachs, AbbVie and IQVIA Holdings (CNBC TV)
Jun-03-24 06:28PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
May-28-24 06:04AM	Analysis-Weight-loss drug forecasts jump to $150 billion as supply grows (Reuters)
May-24-24 11:17AM	Here's Why You Should Hold on to IQVIA (IQV) Stock for Now (Zacks)
08:00AM	Loading…
May-14-24 08:00AM	U.S. Medicines Spending Grew in 2023 as Greater Access Offset COVID-19-related Decline, Says IQVIA Institute (Business Wire)
May-09-24 04:15PM	IQVIA CFO Ron Bruehlman to Speak at the Bank of America Health Care Conference on May 14, 2024 (Business Wire)
May-07-24 06:49AM	Stifel Adjusts Price Target on IQVIA Holdings to $288 From $294 (MT Newswires)
May-04-24 09:27AM	IQVIA Holdings Inc. (NYSE:IQV) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-03-24 12:11PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
11:49AM	UBS Adjusts Price Target on IQVIA Holdings to $295 From $300, Maintains Buy Rating (MT Newswires)
11:17AM	Deutsche Bank Adjusts Price Target on IQVIA Holdings to $275 From $280 (MT Newswires)
11:00AM	Jefferies Adjusts Price Target on IQVIA to $266 From $281 (MT Newswires)
10:07AM	Morgan Stanley Adjusts Price Target on IQVIA to $270 From $275 (MT Newswires)
09:43AM	Truist Adjusts IQVIA Holdings' Price Target to $292 From $297, Keeps Buy Rating (MT Newswires)
09:40AM	Here's Why IQVIA Holdings (IQV) is a Strong Value Stock (Zacks)
09:31AM	Baird Adjusts Price Target on IQVIA to $245 From $254 (MT Newswires)
08:11AM	Leerink Partners Adjusts Price Target on IQVIA to $278 From $290 (MT Newswires)
07:09AM	Evercore ISI Adjusts Price Target on IQVIA to $250 From $275 (MT Newswires)
03:32AM	IQVIA Holdings Inc (IQV) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ... (GuruFocus.com)
01:05AM	Decoding IQVIA Holdings Inc (IQV): A Strategic SWOT Insight (GuruFocus.com)
12:13AM	Q1 2024 IQVIA Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
May-02-24 11:55AM	IQV Stock Earnings: IQVIA Hldgs Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
11:47AM	IQVIA (IQV) Surpasses Earnings & Revenue Estimates in Q1 (Zacks)
10:12AM	IQVIA Holdings Inc (IQV) First Quarter 2024 Earnings: Surpasses Revenue Estimates (GuruFocus.com)
08:10AM	IQVIA Holdings (IQV) Tops Q1 Earnings and Revenue Estimates (Zacks)
08:04AM	IQVIA Holdings Q1 Adjusted Earnings, Revenue Increase (MT Newswires)
07:11AM	IQVIA: Q1 Earnings Snapshot (Associated Press Finance)
07:00AM	IQVIA Reports First-Quarter 2024 Results (Business Wire)
May-01-24 04:30PM	Analysts Are Pounding the Table on These 3 Stocks: April 2024 (InvestorPlace)
Apr-29-24 10:26AM	IQVIA (IQV) to Report Q1 Earnings: What's in the Offing? (Zacks)
09:16AM	Countdown to IQVIA (IQV) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS (Zacks)
Apr-25-24 11:34AM	20 Fastest Growing Health Tech Companies in the World (Insider Monkey)
10:02AM	IQVIA Holdings (IQV) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Apr-24-24 12:34PM	10 Stocks Hedge Funds Are Talking About (Insider Monkey)
Apr-23-24 09:00AM	IQVIA Celebrates Wendy Stewart and Susan Barnes, Winners of Healthcare Businesswoman's Association Luminary and Rising Star Awards (Business Wire)
Apr-18-24 05:00PM	19 Best Alternatives to Discord in 2024 (Insider Monkey)
Apr-17-24 12:00PM	Reasons to Retain IQVIA (IQV) Stock in Your Portfolio Now (Zacks)
Apr-15-24 04:15PM	IQVIA to Announce First-Quarter 2024 Results on May 2, 2024 (Business Wire)
Apr-08-24 04:01PM	IQVIA and Salesforce Expand Global Partnership to Accelerate the Development of Life Sciences Cloud (Business Wire)
07:41AM	Should You Invest in IQVIA Holdings (IQV)? (Insider Monkey)
Apr-04-24 09:40AM	Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term (Zacks)
09:08AM	5 Stocks Hedge Funds Are Investing In (Insider Monkey)
Apr-02-24 11:39AM	IQVIA (IQV) Appreciates 24% in a Year: Here's What to Know (Zacks)
Mar-20-24 07:44PM	25 Countries With Limited Access To Healthcare (Insider Monkey)
Mar-15-24 01:38PM	Lilly weight-loss drug Zepbound new US prescriptions surpass Wegovy for first time (Reuters)
11:30AM	IQVIA (IQV) Up 5.3% Since Last Earnings Report: Can It Continue? (Zacks)
Mar-13-24 12:07PM	IQVIA (IQV) Gains From Global IT Framework, Liquidity Low (Zacks)
Mar-06-24 04:15PM	IQVIA CFO Ron Bruehlman to Speak at Barclays Annual Global Healthcare Conference on March 13, 2024 (Business Wire)
Feb-27-24 08:00AM	Veeva's Upside May Be Capped as Revenue Growth Slows (GuruFocus.com)
Feb-26-24 08:00AM	IQVIA Publishes its 2023 Environmental, Social and Governance Report (Business Wire)
Feb-23-24 09:00AM	Global Biopharma R&D Boasts Increased Funding, Productivity and Product Launches in 2023, says IQVIA Institute Report (Business Wire)
Feb-21-24 04:15PM	IQVIA CFO Ron Bruehlman to Speak at Citis Unplugged Medtech and Life Sciences Access Day on February 29, 2024 (Business Wire)
Feb-16-24 12:02AM	Decoding IQVIA Holdings Inc (IQV): A Strategic SWOT Insight (GuruFocus.com)
Feb-15-24 05:34PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
10:39AM	IQVIA Holdings Inc. (NYSE:IQV) Q4 2023 Earnings Call Transcript (Insider Monkey)
01:30AM	Q4 2023 IQVIA Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-14-24 06:29PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research) +13.10%
01:00PM	IQVIA Holdings (IQV) Q4 Earnings & Revenues Beat Estimates (Zacks)
09:30AM	Compared to Estimates, IQVIA (IQV) Q4 Earnings: A Look at Key Metrics (Zacks)
08:10AM	IQVIA Holdings (IQV) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
07:36AM	IQVIA Holdings Inc (IQV) Posts Strong Year-Over-Year Growth in Q4 and Full-Year 2023 Earnings (GuruFocus.com)
07:33AM	IQVIA Holdings Guides FY24 In Line With Estimates - Update (RTT News)
07:16AM	IQVIA: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	IQVIA Reports Fourth-Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance (Business Wire)
Feb-09-24 09:26AM	IQVIA (IQV) to Report Q4 Earnings: What's in the Offing? (Zacks)
09:15AM	Stay Ahead of the Game With IQVIA (IQV) Q4 Earnings: Wall Street's Insights on Key Metrics (Zacks)
Feb-06-24 09:00AM	IQVIA Named to Fortune World's Most Admired Companies List, Ranked #1 in Its Sector for the Third Consecutive Year (Business Wire)
Jan-24-24 04:15PM	IQVIA to Announce Fourth-Quarter and Full-Year 2023 Results on February 14, 2024 (Business Wire)
Jan-18-24 12:49PM	Here's Why You Should Invest in IQVIA Holdings (IQV) Now (Zacks)
Jan-17-24 06:00AM	Global Medicine Spending to Reach $2.3 Trillion by 2028 as More Patients Get Access to Better Therapies, Says IQVIA Institute Report (Business Wire)
Jan-10-24 06:29PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
06:16PM	If You Can Only Buy One Biotech Stock in January, It Better Be One of These 3 Names (InvestorPlace)
Jan-03-24 10:31AM	IQVIA (IQV) Climbs 17% in 3 Months: Here's What to Know (Zacks)
Jan-02-24 08:15AM	3 Charts For Investors to Watch Tuesday: IQVIA Holdings, BGC Group, WGMI ETF (Investopedia)

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm's life science clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BOUSBIB ARI	See Remarks	Mar 01 '24	Option Exercise	65.16	42,847	2,791,911	828,430	Mar 04 05:28 PM
BOUSBIB ARI	See Remarks	Mar 01 '24	Sale	250.53	31,678	7,936,193	796,752	Mar 04 05:28 PM
STAUB W RICHARD	See Remarks	Feb 29 '24	Sale	247.80	14,100	3,494,034	15,945	Mar 04 05:27 PM
Knightly Kevin C	See Remarks	Feb 28 '24	Option Exercise	87.40	13,206	1,154,211	13,858	Mar 01 05:07 PM
Knightly Kevin C	See Remarks	Feb 28 '24	Sale	250.17	8,607	2,153,176	5,251	Mar 01 05:07 PM
Knightly Kevin C	See Remarks	Feb 16 '24	Option Exercise	78.21	12,149	950,173	18,061	Feb 21 05:07 PM
Knightly Kevin C	See Remarks	Feb 16 '24	Sale	241.10	13,468	3,247,165	652	Feb 21 05:07 PM
Sherbet Eric	See Remarks	Feb 16 '24	Sale	241.50	1,000	241,500	20,836	Feb 21 05:08 PM
Knightly Kevin C	See Remarks	Dec 01 '23	Option Exercise	62.26	18,491	1,151,185	20,464	Dec 05 05:01 PM
Knightly Kevin C	See Remarks	Dec 01 '23	Sale	214.03	13,117	2,807,472	7,347	Dec 05 05:01 PM
Panagos Constantinos	See Remarks	Sep 19 '23	Option Exercise	149.45	26,186	3,913,563	40,436	Sep 21 05:01 PM
Panagos Constantinos	See Remarks	Sep 19 '23	Sale	208.67	27,317	5,700,340	14,250	Sep 21 05:01 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

IQV

IQVIA Holdings Inc

Upgrade your FINVIZ experience